- Home
- FGEN vs PLUR Comparison
FGEN vs PLUR Comparison
Compare FGEN & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- PLUR
- Stock Information
- Founded
- FGEN 1993
- PLUR 2001
- Country
- FGEN United States
- PLUR Israel
- Employees
- FGEN N/A
- PLUR N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FGEN Health Care
- PLUR Health Care
- Exchange
- FGEN Nasdaq
- PLUR Nasdaq
- Market Cap
- FGEN 38.4M
- PLUR 44.7M
- IPO Year
- FGEN 2014
- PLUR N/A
- Fundamental
- Price
- FGEN $11.48
- PLUR $4.76
- Analyst Decision
- FGEN Strong Buy
- PLUR Strong Buy
- Analyst Count
- FGEN 2
- PLUR 1
- Target Price
- FGEN $146.50
- PLUR $12.00
- AVG Volume (30 Days)
- FGEN 64.8K
- PLUR 12.5K
- Earning Date
- FGEN 08-11-2025
- PLUR 09-12-2025
- Dividend Yield
- FGEN N/A
- PLUR N/A
- EPS Growth
- FGEN N/A
- PLUR N/A
- EPS
- FGEN N/A
- PLUR N/A
- Revenue
- FGEN $7,346,000.00
- PLUR $1,034,000.00
- Revenue This Year
- FGEN N/A
- PLUR $395.40
- Revenue Next Year
- FGEN N/A
- PLUR $186.32
- P/E Ratio
- FGEN N/A
- PLUR N/A
- Revenue Growth
- FGEN N/A
- PLUR 203.23
- 52 Week Low
- FGEN $4.50
- PLUR $3.33
- 52 Week High
- FGEN $21.94
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- FGEN 59.87
- PLUR 46.17
- Support Level
- FGEN $10.65
- PLUR $4.85
- Resistance Level
- FGEN $12.60
- PLUR $5.12
- Average True Range (ATR)
- FGEN 0.82
- PLUR 0.32
- MACD
- FGEN -0.06
- PLUR -0.03
- Stochastic Oscillator
- FGEN 55.20
- PLUR 22.43
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.